<DOC>
	<DOCNO>NCT01025791</DOCNO>
	<brief_summary>A three panel study , determine MK8266 give single dose sufficiently safe well tolerate . Panel A B consist healthy young male Panel C consist subject mild moderate hypertension .</brief_summary>
	<brief_title>A Single Dose Study MK8266 ( 8266-001 )</brief_title>
	<detailed_description />
	<criteria>For Panel A B Subject healthy male 18 45 year age . For Panel C subject male essential hypertension 18 55 year age Subject nonsmoker Subject history stroke , chronic seizure major neurological disorder Subject disability interfere rise sit position stand position Subject personal family history bleed clot disorder Subject history cancer Subject unable refrain anticipates use prescription nonprescription drug study Subject consume excessive amount caffeine alcohol Subject major surgery , donate blood participate another investigational study past 4 week</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>